Skip to content

The Enhancement of the Neoadjuvant Chemotherapy of Breast Cancer Combined Ultrasound and Microbubbles

The Enhancement of the Neoadjuvant Chemotherapy of Breast Cancer Combined Ultrasound and Microbubbles

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056718
Enrollment
Unknown
Registered
2022-02-11
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Experiemental group:Ultrasound irradiation
Control group:Blank control

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed breast cancer; 2. Female, aged 18 to 75 years; 3. Single acoustic accessible lesion evaluated by Ultrasound, Computed Tomography(CT), or Magnetic Resonance Imaging(MRI); 4. Expected survival time>=5 months; Performance Status(PS) 0-2; 5. Blood routine examination: WBC>=3.5?10^9/L; ANC>=1.5?10^9/L; PLT>=80?10^9/L; Hb>=90g/L; 6. Hepatic and renal function test: ALT, AST<=2.5 times that of the upper limit of normal; UreaCrea<=1.25 times that of the upper limit of normal; 7. No known symptoms of heart failure and respiratory function insufficiency; 8. No known previous malignant tumor history; 9. Good treatment compliance, no mental disorders; 10. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. During pregnancy or lactation; 2. Allergic to chemotherapy substances or allergic constitution; 3. With massive ascites; 4. Positive lung, brain, or other organs metastasis; 5. During the therapeutic course of other anticancer drugs or radiotherapy; 6. Participating in other clinical trials or less than 4 weeks since the accomplishment of previous chemotherapy.

Design outcomes

Primary

MeasureTime frame
Tumor size;Quantitative Analysis of Ultrasound Contrast;

Countries

China

Contacts

Public ContactZheng Liu

Second Affiliated Hospital of Army Medical University

liuzhengs@163.com+86 13983406200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026